HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsutaro Hayashi Selected Research

Neoplasm Metastasis (Metastasis)

12/2021Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor.
2/2021Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab.
10/2020Primary adenocarcinoma of the rete testis with elevated serum CA19-9 antigen levels.
7/2020Renal metastasis from primary hepatocellular carcinoma: a case report.
7/2019Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade.
10/2017Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma.
5/2017Impact of neutrophil-to-lymphocyte ratio on effects of targeted therapy for metastatic renal cell carcinoma patients with extrapulmonary metastasis.
3/2013Expression of miR-486 is a potential prognostic factor after nephrectomy in advanced renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsutaro Hayashi Research Topics

Disease

39Neoplasms (Cancer)
01/2024 - 08/2008
26Renal Cell Carcinoma (Grawitz Tumor)
03/2023 - 03/2013
20Prostatic Neoplasms (Prostate Cancer)
11/2023 - 08/2008
17Urinary Bladder Neoplasms (Bladder Cancer)
05/2024 - 10/2011
17Carcinoma (Carcinomatosis)
11/2023 - 10/2011
8Neoplasm Metastasis (Metastasis)
12/2021 - 03/2013
4Stomach Neoplasms (Stomach Cancer)
03/2021 - 11/2009
3Inflammation (Inflammations)
02/2023 - 01/2016
2Kidney Neoplasms (Kidney Cancer)
10/2022 - 10/2017
2Non-Muscle Invasive Bladder Neoplasms
01/2022 - 01/2021
1Hydronephrosis
05/2024
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
01/2024
1Frailty
11/2023
1Necrosis
10/2022
1Hemorrhagic Cystitis
07/2022
1Dihydropyrimidine Dehydrogenase Deficiency
01/2022
1Thrombosis (Thrombus)
01/2022
1Hypercalcemia (Milk Alkali Syndrome)
12/2021
1Hematuria
11/2021
1Epilepsy (Aura)
10/2021
1Autoimmune Diseases of the Nervous System
10/2021
1Encephalitis (Encephalitis, Rasmussen)
10/2021
1Seizures (Absence Seizure)
10/2021
1Kleefstra Syndrome
07/2021
1Intellectual Disability (Idiocy)
07/2021
1Hypogonadism (Hypergonadotropic Hypogonadism)
06/2021
1Infections
03/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2021
1Pain (Aches)
01/2021
1Postoperative Pain
01/2021
1Ureterocele
01/2021
1Chronic Renal Insufficiency
01/2021
1Fatigue
01/2021
1Small Cell Carcinoma
11/2020

Drug/Important Bio-Agent (IBA)

12Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2009
10Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2010
8Tyrosine Kinase InhibitorsIBA
01/2023 - 11/2017
6pembrolizumabIBA
11/2023 - 11/2020
6Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2013
6C-Reactive ProteinIBA
10/2022 - 08/2014
6Immune Checkpoint InhibitorsIBA
10/2022 - 01/2019
6Ampicillin (Omnipen)FDA LinkGeneric
04/2016 - 07/2010
5Sunitinib (Sutent)FDA Link
10/2021 - 10/2017
4Prostate-Specific Antigen (Semenogelase)IBA
10/2023 - 01/2013
4GemcitabineFDA Link
01/2023 - 01/2013
3RNA (Ribonucleic Acid)IBA
01/2022 - 03/2013
3Docetaxel (Taxotere)FDA Link
01/2021 - 07/2014
3taxaneIBA
01/2021 - 01/2020
2Indicators and Reagents (Reagents)IBA
11/2023 - 10/2022
2Phenobarbital (Luminal)FDA Link
01/2023 - 01/2017
2AntigensIBA
10/2022 - 10/2020
2DNA (Deoxyribonucleic Acid)IBA
10/2022 - 01/2017
2Histones (Histone)IBA
07/2021 - 01/2020
2Lysine (L-Lysine)FDA Link
07/2021 - 01/2020
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2021 - 04/2020
2bicalutamide (Casodex)FDA LinkGeneric
10/2020 - 01/2019
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2020 - 01/2020
2CytokinesIBA
01/2020 - 01/2019
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
02/2019 - 02/2014
2InterferonsIBA
05/2013 - 03/2013
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
05/2024
1NivolumabIBA
03/2023
1Heme Oxygenase-1IBA
02/2023
1antineoplaston A10 (A 10)IBA
01/2023
1AnnexinsIBA
01/2023
1Mucin-1 (CA 15-3 Antigen)IBA
12/2022
1Pattern Recognition ReceptorsIBA
10/2022
1Immunoconjugates (Immunoconjugate)IBA
10/2022
1Serum AlbuminIBA
10/2022
1PlatinumIBA
02/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022
1KinesinsIBA
10/2021
1LigandsIBA
10/2021
1Monoclonal AntibodiesIBA
10/2021
1MethyltransferasesIBA
07/2021
1Hemoglobins (Hemoglobin)IBA
02/2021
1Analgesics (Analgesic Drugs)IBA
01/2021
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2021
1Etoposide (VP 16)FDA LinkGeneric
11/2020
1B7-H1 AntigenIBA
11/2020

Therapy/Procedure

21Therapeutics
10/2023 - 01/2013
10Nephrectomy
01/2024 - 03/2013
8Drug Therapy (Chemotherapy)
07/2023 - 01/2013
6Prostatectomy (Retropubic Prostatectomy)
11/2023 - 08/2008
6Castration
10/2023 - 01/2014
3Cystectomy
01/2024 - 08/2020
3Nephroureterectomy
11/2023 - 09/2018
2Catheters
07/2022 - 01/2022
2Urinary Catheters
01/2022 - 05/2011
2Transurethral Resection of Bladder
11/2021 - 01/2021
2Adrenalectomy
01/2021 - 01/2020
2Molecular Targeted Therapy
01/2016 - 08/2014
1Urinary Diversion (Ileal Conduit)
01/2024
1Perioperative Period
01/2024
1Precision Medicine
10/2023
1Hematopoietic Stem Cell Transplantation
07/2022
1Palliative Care (Palliative Therapy)
11/2021
1Immunotherapy
10/2021
1Aftercare (After-Treatment)
10/2021
1Blood Transfusion (Blood Transfusions)
01/2021